LAURA LEBLANC: Open Payments
NPI 1679589758 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,630 in 72 payments from 11 companies in 2025. Trend: 2023 $1,096 · 2024 $1,938 · 2025 $1,630
Food & beverage: $1,447Education: $183
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 22 | $750 |
| ABBVIE INC. | 35 | $426 |
| Merit Medical Systems Inc | 1 | $130 |
| Exact Sciences Corporation | 3 | $77 |
| Madrigal Pharmaceuticals | 2 | $68 |
| GENZYME CORPORATION | 3 | $55 |
| Gilead Sciences, Inc. | 2 | $44 |
| Ipsen Biopharmaceuticals, Inc | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| Olympus America Inc. | 1 | $19 |
Products named: TREMFYA, RINVOQ, ESOPHYX, MAVYRET, REZDIFFRA, DUPIXENT, Cologuard Collection Kit, SKYRIZI.
Industry payments across NM — which companies pay providers there.
